Peter Sanguinetti - Australian Pharmaceutical Insider

API -- Australia Stock  

AUD 1.61  0.02  1.26%

Chief Legal Counsel, Company Secretary
Mr. Peter F. Sanguinetti serves as General Counsel, Company Secretary of Australian Pharmaceutical Industries Ltd., since November 2007. Mr Sanguinetti BJuris, LLB, GAICD has extensive experience and was previously Company Secretary and General Counsel of Kodak Pty Ltd for 9 years, responsible for legal and company secretarial activities for the Kodak group across Asia. Mr Sanguinetti was also a nonexecutive director of HPAL Limited from January 2005 to November 2007. On 2 June 2009.
  Executive Since 2007      
61 3 8855 3000  http://www.api.net.au

Management Efficiency

The company has return on total asset (ROA) of 3.69 % which means that it generated profit of $3.69 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 8.67 % meaning that it generated $8.67 on every $100 dollars invested by stockholders.
The company has accumulated 52.15 M in total debt with debt to equity ratio (D/E) of 9.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Australian Pharmaceutical Industries Limited has Current Ratio of 1.39 which is within standard range for the sector.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Bernard RonchiCSL Limited
2015
Robert CorringhamBionomics Limited
2016
Mark EdwardsMedical Developments Internatio
2014
Lisa PendleburyMayne Pharma Group Limited
N/A
Tony ColasinBionomics Limited
2015
Jose IglesiasBionomics Limited
2012
Jack MoschakisBionomics Limited
2015
Julie MeldrumMesoblast Limited
N/A
Jonathan RabinovitzHunter Hall Australian Value Tr
null%
John LevyCSL Limited
2017
John McMannisMesoblast Limited
2011
Andrew CuthbertsonCSL Limited
2000
Peter HowardMesoblast Limited
2011
Dennis WrightClinuvel Pharmaceuticals Limite
2012
Paul SimmonsMesoblast Limited
2011
Geraldine StortonMesoblast Limited
N/A
Charlie HarrisonMesoblast Limited
2014
Fiona MeadCSL Limited
2018
Edward BaileyCSL Limited
2017
Jens MikkelsenBionomics Limited
2015
Donna SkerrettMesoblast Limited
2011

Entity Summary

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia. Australian Pharmaceutical operates under Medical Distribution classification in Australia and traded on Australian Securities Exchange.Australian Pharmaceutical Industries Limited (API) is traded on Australian Securities Exchange in Australia. It is located in 250 Camberwell Road and employs 18 people.

Australian Pharmaceutical Leadership Team

Stock Performance Indicators

Did you try this?

Run Money Managers Now
   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Money Managers

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Australian Pharmaceutical and CSL Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">